Post-Issuance Options: The Benefits and Risks of Reexamination and Reissue

Copywrong: Authors Miss the Mark(et Harm) when Arguing Meta Didn’t Engage in Fair Use

MBHB Partner Kevin Noonan Shares Insights on Impacts of Potential NIH Funding Cuts on Biopharma Innovation

Pirates of the Claudeibbean: Judge Alsup Splits the Baby on AI Fair Use

© 2025 McDonnell Boehnen Hulbert & Berghoff LLP snippets is a trademark of McDonnell Boehnen Hulbert & Berghoff LLP. All rights reserved. The information contained in this newsletter reflects the understanding and opinions of the author(s) and is provided to you for informational purposes only. It is not intended to and does not represent legal advice. MBHB LLP does not intend to create an attorney–client relationship by providing this information to you. The information in this publication is not a substitute for obtaining legal advice from an attorney licensed in your particular state. snippets may be considered attorney advertising in some states.

Post-Issuance Options: The Benefits and Risks of Reexamination and Reissue

Practices & Technologies

Copywrong: Authors Miss the Mark(et Harm) when Arguing Meta Didn’t Engage in Fair Use

MBHB Partner Kevin Noonan Shares Insights on Impacts of Potential NIH Funding Cuts on Biopharma Innovation

Pirates of the Claudeibbean: Judge Alsup Splits the Baby on AI Fair Use

Private: Sydney R. Kokjohn

Private: A. Grace Klock